Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition BSE India Intimation of the acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Limited by Auro Pharma Limited, a wholly owned subsidiary of the Company.